Davern Capital Partners »

Insmed shares owned by Davern Capital Partners

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Davern Capital Partners from 13F filings

Historical chart of Davern Capital Partners investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Davern Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Davern Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $30M 183k 163.52

More positions owned by Davern Capital Partners

Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Insmed Com Par $.01 (INSM)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Biontech Se Sponsored Ads (BNTX)
Argenx Se Sponsored Adr (ARGX)
Eli Lilly & Co. (LLY)
Royalty Pharma Shs Class A (RPRX)
Roivant Sciences SHS (ROIV)
Legend Biotech Corp Sponsored Ads (LEGN)
Mineralys Therapeutics (MLYS)
Abivax Sa Sponsored Ads (ABVX)
Generate Biomedicines Com Shs
Procept Biorobotics Corp (PRCT)

View all positions for Davern Capital Partners

Top funds holding Insmed

Vanguard Group
Darwin Global Management
BlackRock
FMR
Vanguard Portfolio Management
Vanguard Capital Management
Baker Bros. Advisors
Artisan Partners Limited Partnership
D. E. Shaw & Co
Capital Research and Management Company - Division 3
State Street Corporation
Rtw Investments
Geode Capital Management
Ameriprise Financial
Franklin Resources

View all funds holding Insmed